PROGRESSIVE CARE, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.72 USD | -7.03% |
|
-16.10% | -45.23% |
| May. 15 | Correction: Earnings Flash (NXPL, RXMD) NEXTPLAT Posts Q1 Revenue $17.5M | MT |
| May. 15 | Progressive Care, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
| Sales 2022 | 40.6M | Sales 2023 | 49.73M | Capitalization | 19.54M |
|---|---|---|---|---|---|
| Net income 2022 | -6M | Net income 2023 | -19M | EV / Sales 2022 | 0.44 x |
| Net cash position 2022 | 3.73M | Net cash position 2023 | 6.23M | EV / Sales 2023 | 0.27 x |
| P/E ratio 2022 |
-2.94
x | P/E ratio 2023 |
-1.33
x | Employees | 143 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 51.79% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -7.03% | ||
| 1 week | -16.10% | ||
| Current month | -7.03% | ||
| 1 month | -16.10% | ||
| 3 months | -36.30% | ||
| 6 months | -44.74% | ||
| Current year | -45.23% |
1 week
1.60
1.85
1 month
1.372.48
Current year
0.403.50
1 year
0.406.05
3 years
0.3012.60
5 years
0.3039.00
10 years
0.3053.18
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 22-09-12 | |
Cecile Munnik
DFI | Director of Finance/CFO | 47 | 20-06-30 |
Pamela Roberts
COO | Chief Operating Officer | 49 | 23-04-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 22-09-12 | |
Jervis Hough
BRD | Director/Board Member | 48 | 17-07-31 |
Joseph Ziegler
BRD | Director/Board Member | - | 21-12-20 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-03 | 1.72 | -7.03% | 1,402 |
| 24-05-30 | 1.85 | +5.71% | 1,420 |
| 24-05-29 | 1.75 | 0.00% | 699 |
Delayed Quote OTC Markets, June 03, 2024 at 03:18 pm EDT
More quotes
Progressive Care, Inc. is a personalized healthcare services and technology provider. The Company operates through two segments: Pharmacy Operations and Third-Party Administration. The Pharmacy Operations segment provides prescription pharmaceuticals, compounded medications, tele-pharmacy services, COVID-19 related diagnostics and vaccinations, anti-retroviral medications, medication therapy management, the supply of prescription medications to long-term care facilities, medication adherence packaging, and contracted pharmacy services for 340B covered entities under the 340B Drug Discount Pricing Program. The Third-Party Administration segment provides data management and reporting services to support health care organizations. It offers services in a variety of languages, including English, Spanish, French, Creole, Portuguese, Ukrainian and Russian. Through its wholly owned subsidiary, ClearMetrX, it offers data management and reporting services to support health care organizations.
Sector
Drug Retailers
Calendar
2024-08-12
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -45.23% | 10.73M | |
| -13.95% | 8.25B | |
| -9.35% | 359M | |
| -0.21% | 267M | |
| +11.11% | 229M | |
| -10.09% | 87M | |
| -44.97% | 86.89M | |
| +28.21% | 63.7M |
- Stock Market
- Equities
- RXMD Stock
